Bishop MR - Search Results

1

Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.

Vose JM, Anderson JR, Bierman PJ, Bast M, Weisenburger D, Chan WC, Bishop MR, Armitage JO. Vose JM, et al. Among authors: bishop mr. Semin Hematol. 1994 Apr;31(2 Suppl 3):4-8. Semin Hematol. 1994. PMID: 7521065 Clinical Trial. No abstract available.

2

Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.

Kessinger A, Vose JM, Bierman PJ, Bishop M, Armitage JO. Kessinger A, et al. J Hematother. 1993 Fall;2(3):361-2. doi: 10.1089/scd.1.1993.2.361. J Hematother. 1993. PMID: 7921996 Clinical Trial.

3

Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.

Freeman M, Vose J, Bennett C, Anderson J, Kessinger A, Turner K, Pierson J, Bishop M, Bierman P, Armitage J. Freeman M, et al. Bone Marrow Transplant. 1999 Sep;24(6):679-84. doi: 10.1038/sj.bmt.1701949. Bone Marrow Transplant. 1999. PMID: 10490736

4

Salvage therapy for patients with lymphoma.

Armitage JO, Vose JM, Bierman PJ, Bishop MR. Armitage JO, et al. Among authors: bishop mr. Semin Oncol. 1994 Aug;21(4 Suppl 7):82-5. Semin Oncol. 1994. PMID: 8091246 Review.

5

The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphoma.

Bishop MR, Bierman PJ, Vose JM, Armitage JO. Bishop MR, et al. Ann Oncol. 1993;4 Suppl 1:1-6. doi: 10.1093/annonc/4.suppl_1.s1. Ann Oncol. 1993. PMID: 8101723 Review. No abstract available.

6

High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.

Bierman PJ, Anderson JR, Freeman MB, Vose JM, Kessinger A, Bishop MR, Armitage JO. Bierman PJ, et al. Among authors: bishop mr. Ann Oncol. 1996 Feb;7(2):151-6. doi: 10.1093/oxfordjournals.annonc.a010542. Ann Oncol. 1996. PMID: 8777171 Free article. Clinical Trial.

7

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A. Pavletic SZ, et al. Among authors: bishop mr. Am J Hematol. 2005 Apr;78(4):265-74. doi: 10.1002/ajh.20275. Am J Hematol. 2005. PMID: 15795914 Free article.

8

Clinical outcome of peripheral blood stem cell support.

Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J. Kessinger A, et al. Med Oncol. 1994;11(2):43-6. doi: 10.1007/BF02988829. Med Oncol. 1994. PMID: 7850263 Review.

9

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

Haire WD, Ruby EI, Stephens LC, Reed E, Tarantolo SR, Pavletic ZS, Bierman PJ, Bishop M, Kessinger A, Vose J, Armitage JO. Haire WD, et al. Biol Blood Marrow Transplant. 1998;4(3):142-50. doi: 10.1053/bbmt.1998.v4.pm9923412. Biol Blood Marrow Transplant. 1998. PMID: 9923412 Free article. Clinical Trial.

10

Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.

Kessinger A, Bishop MR, Anderson JR, Armitage JO, Bierman PJ, Reed EC, Tarantolo S, Tempero MA, Vose JM, Warkentin PI. Kessinger A, et al. Among authors: bishop mr. J Hematother. 1995 Apr;4(2):81-4. doi: 10.1089/scd.1.1995.4.81. J Hematother. 1995. PMID: 7543352 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters